Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • LEOSS Study Group - (Autor:in)
  • Klinische Infektiologie
  • Universität zu Köln
  • Universität Regensburg
  • Partnerstandort Bonn-Köln
  • Universitätsklinikum Frankfurt
  • Charité – Universitätsmedizin Berlin
  • Universitätsklinikum Freiburg
  • Klinikum Ingolstadt
  • Technische Universität München
  • Vivantes Humboldt-Klinikum
  • Ludwig-Maximilians-Universität München (LMU)
  • Johannes Wesling Klinikum Minden
  • Universität Heidelberg
  • Universität Witten/Herdecke
  • Robert Bosch Krankenhaus Stuttgart
  • Universitätsklinikum Tübingen
  • Julius-Maximilians-Universität Würzburg
  • Friedrich-Alexander-Universität Erlangen-Nürnberg
  • Kliniken Maria Hilf GmbH
  • Tropenklinik Paul-Lechler Krankenhaus Tuebingen
  • Universitätsklinikum Schleswig-Holstein Campus Kiel
  • Bundeswehrkrankenhaus Koblenz
  • Universitätsklinikum Carl Gustav Carus Dresden
  • Klinikum Leverkusen
  • Helios Klinikum Pirna
  • Malteser Krankenhaus St. Franziskus-Hospital
  • Oberlausitz-Kliniken gGmbH
  • Ruhr-Universität Bochum
  • Elblandklinikum Riesa
  • Agaplesion Bethesda Krankenhaus Bergedorf
  • Medizinische Hochschule Hannover (MHH)
  • Kliniken Südostbayern
  • Hegau-Bodensee-Klinikum Singen
  • Krankenhaus der Augustinerinnen
  • Klinik Preetz
  • St. Vincenz KH Limburg
  • Diakonie Kliniken Hunsrück
  • Saarland Heilstätten GmbH (SHG)

Abstract

Purpose: This study investigates the care provision and the role of infectious disease (ID) specialists during the coronavirus disease-2019 (COVID-19) pandemic. Methods: A survey was conducted at German study sites participating in the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS). Hospitals certified by the German Society of Infectious diseases (DGI) were identified as ID centers. We compared care provision and the involvement of ID specialists between ID and non-ID hospitals. Then we applied a multivariable regression model to analyse how clinical ID care influenced the mortality of COVID-19 patients in the LEOSS cohort. Results: Of the 40 participating hospitals in the study, 35% (14/40) were identified as ID centers. Among those, clinical ID care structures were more commonly established, and ID specialists were always involved in pandemic management and the care of COVID-19 patients. Overall, 68% (27/40) of the hospitals involved ID specialists in the crisis management team, 78% (31/40) in normal inpatient care, and 80% (28/35) in intensive care. Multivariable analysis revealed that COVID-19 patients in ID centers had a lower mortality risk compared to those in non-ID centers (odds ratio: 0.61 (95% CI 0.40–0.93), p = 0.021). Conclusion: ID specialists played a crucial role in pandemic management and inpatient care.

Details

OriginalspracheEnglisch
FachzeitschriftInfection
Frühes Online-Datum16 Aug. 2024
PublikationsstatusElektronische Veröffentlichung vor Drucklegung - 16 Aug. 2024
Peer-Review-StatusJa

Externe IDs

PubMed 39150640
ORCID /0000-0001-9473-3018/work/175764404

Schlagworte

Ziele für nachhaltige Entwicklung

Schlagwörter

  • COVID-19, Healthcare quality, Healthcare research, Infectious diseases medicine, Pandemic, Quality indicators